Accounts filed on 31-03-2016


089545292015-04-012016-03-31falsetruehttp://www.companieshouse.gov.uk/cd:Director12015-04-012016-03-31http://www.companieshouse.gov.uk/pt:PlantMachinery2016-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12015-04-012016-03-31http://www.companieshouse.gov.uk/pt:PlantMachinery2015-04-012016-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12016-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12015-03-31http://www.companieshouse.gov.uk/2014-04-012015-03-31http://www.companieshouse.gov.uk/2015-04-012016-03-31http://www.companieshouse.gov.uk/2015-03-31http://www.companieshouse.gov.uk/2016-03-31http://www.companieshouse.gov.uk/cd:EntityAccountantsOrAuditors2015-04-012016-03-31http://www.companieshouse.gov.uk/2015-03-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 08954529

Blair Biomedical Consulting Ltd

ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31/03/2016

Prepared By:
Anstee Gorst
Ground Floor Offices, Unit 4 Eaton Court
Colmworth Business Park
Eaton Socon, St Neots
Cambridgeshire
PE19 8ER

Blair Biomedical Consulting Ltd

ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31/03/2016
INDEX TO THE ACCOUNTS
Abbreviated Balance Sheet2
Notes to the Abbreviated Accounts3
The company's registered number is 08954529

Blair Biomedical Consulting Ltd

Registered Number: 08954529
BALANCE SHEET AT 31/03/2016
20162015
Notes££
FIXED ASSETS
Tangible assets2612-
CURRENT ASSETS
Debtors (amounts falling due within one year)336,7369,006
Cash at bank and in hand12,830595
49,5669,601
CREDITORS: Amounts falling due within one year35,4058,952
NET CURRENT ASSETS14,161649
TOTAL ASSETS LESS CURRENT LIABILITIES14,773649
PROVISIONS FOR LIABILITIES122-
NET ASSETS14,651649
CAPITAL AND RESERVES
Called up share capital4100100
Profit and loss account14,551549
SHAREHOLDERS' FUNDS14,651649
For the year ending 31/03/2016 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 19/07/2016 and signed on their behalf by
Edward Blair
Director

Blair Biomedical Consulting Ltd

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/03/2016
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).
1b. Cash Flow Statement
The Company is exempt from including a statement of cash flows in its accounts in accordance with Financial Reporting Standard for Smaller Entities (effective January 2015).
1c. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Plant and Machineryreducing balance 25%
1d. Taxation
Corporation tax payable is provided on taxable profits at the current rates.
Provision is made for deferred taxation in so far as a liability or asset has arisen as a result of transactions that had occurred by the balance sheet date and have given rise to an obligation to pay more tax in the future, or the right to pay less tax in the future. An asset has not been recognised to the extent that the transfer of economic benefits in the future is uncertain. Deferred tax assets and liabilities recognised have not been discounted.
1e. Turnover
Turnover represents the invoiced value of goods and services supplied by the company, net of value added tax and trade discounts.

Blair Biomedical Consulting Ltd

2. TANGIBLE FIXED ASSETS
Plant and
MachineryTotal
££
Cost
Additions653653
At 31/03/2016653653
Depreciation
For the year4141
At 31/03/20164141
Net Book Amounts
At 31/03/2016612612
3. DEBTORS 20162015
££
Amounts falling due within one year:
Trade debtors9,876-
Other debtors26,8609,006
36,7369,006
4. SHARE CAPITAL 20162015
££
Allotted, issued and fully paid:
100 Class 1 shares of £1 each100100
100100
5. TRANSACTIONS WITH DIRECTORS
During the year a loan was granted to Edward Blair, director of the company. The loan balance outstanding at 31 March 2016 totallled £26412 (2015 £8906)

Blair Biomedical Consulting Ltd

6. CONTROLLING PARTY
The controlling party is Edward Blair, director of the company.